Pregnancy complications in polycystic ovary syndrome patients

References

• Fauser BC, Tarlatzis BC and Rebar RWet al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRFJASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97:28–38
   PubMed Web of Science ®Google Scholar
• Zawadzki JK and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP and Merriam GR, eds. Polycystic ovary syndrome. Oxford: Blackwell; 2002:59–69
   Google Scholar
• Katulski K, Bornstein S and Figiel M. Typical hormonal profile s are accompanied by increased immunoreactivity of theca folliculi steroid 17 alpha hydroxylase P450 in polycystic ovary syndrome. J Endocrinol Invest 1998;21:304–9
   PubMed Web of Science ®Google Scholar
• Wild RA, Carmina E and Diamanti-Kandarakis Eet al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010;95:2038–49
   PubMed Web of Science ®Google Scholar
• Boivin J. A review of psychosocial interventions in infertility. Soc Sci Med 2003;57:2325–41
   PubMed Web of Science ®Google Scholar
• Katulski K and Meczekalski B. Objective assessment of hyperandrogenism and modern ideas on PCOS treatment. Arch Perinat Med 2011;17:210–16
   Google Scholar
• Kamalanathan S, Sahoo JP and Sathyapalan T. Pregnancy in polycystic ovary syndrome. Indian J Endocrinol Metab 2013;17:37–43
   PubMedGoogle Scholar
• Weghofer A, Munne S and Chen Set al. Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007;88:900–5
   PubMed Web of Science ®Google Scholar
• Lindenberg S. New approach in patients with polycystic ovaries, lessons for everyone. Fertil Steril 2013;99:1170–2
   PubMed Web of Science ®Google Scholar
• Rice S, Christoforidis N and Gadd Cet al. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from an ovulatory women with polycystic ovaries. Hum Reprod 2005;20:373–81
   PubMed Web of Science ®Google Scholar
• Wood JR, Dumesic DA and Abbott DHet al. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 2007;92:705–13
   PubMed Web of Science ®Google Scholar
• Harris SE, Maruthini D and Tang Tet al. Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndrome. Hum Reprod 2010;25:2305–15
   PubMed Web of Science ®Google Scholar
• Katulski K, Meczekalski B, Ghrelin and fertility. Prz. Menopauz 2012;11:26–30
   Google Scholar
• Hickey TE, Legro RS and Norman RJ. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:2789–91
   PubMed Web of Science ®Google Scholar
• Bruyneel A, Cattea u-Jonard S and Decanter Cet al. Polycystic ovary syndrome: what are the obstetrical risks? Gynecol Obstet Fertil 2014;42:104–11
   PubMedGoogle Scholar
• Hu S, Leonard A, Seifalian A and Hardiman P. Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. Hum Reprod 2007;22:1532–9
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Ladrón de Guevara A and Villarroel ACet al. Polycystic ovary syndrome and pregnancy. Rev Med Chil 2012;140:919–25
   PubMed Web of Science ®Google Scholar
• ACOG. Committee on Practice Bulletins-Obstetrics. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2011;98:159–67
   Google Scholar
• de Vries MI, Dekker GA and Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. Eur J Obstet Gynecol Reprod Biol 2008;76:91–5
   Google Scholar
• Kashyap S and Claman P. Polycystic ovary disease and the risk of pregnancy-induced hypertension. J Reprod Med 2009;45:991–4
   Google Scholar
• Qin JZ, Pang LH and Li MJet al. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol 2013;11:56
   PubMed Web of Science ®Google Scholar
• Hattersley AT and Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 2009;353:1789–92
   Google Scholar
• Shayeb AG, Harrild K and Bhattacharya S. Birth weight and ovulatory dysfunction. BJOG 2014;121:281–9
   PubMed Web of Science ®Google Scholar
• Ibanez L, Potau N, Francois L and de Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 2008;83:3558–62
   Google Scholar
• Benitez R, Sir-Petermann T and Palomino Aet al. Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome. Rev Med Chil 2011;129:707–12
   Google Scholar
• Laitinen J, Taponen S and Martikainen Het al. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. lnt J Obes Relat Metab Disord 2003;27:710–15
   PubMed Web of Science ®Google Scholar
• Palomba S, Falbo A and Russo Tet al. Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes. BJOG 2010;117:711–21
   PubMed Web of Science ®Google Scholar
• Nahuis MJ, Oude Lohuis EJ and Bayram Net al. Pregnancy complications and metabolic disease in women with clomiphene citrate-resistant anovulation randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotropins: a 10-year follow-up. Fertil Steril 2014;101:270–4
   PubMed Web of Science ®Google Scholar
• Wax JR. Risks and management of obesity in pregnancy: current controversies. Curr Opin Obstet Gynecol 2009;21:117–23
   PubMed Web of Science ®Google Scholar
• Galazis N, Docheva N, Nicolaides KH and Atiomo W. Proteomic biomarkers of preterm birth risk in women with polycystic ovary syndrome (PCOS): a systematic review and biomarker database integration. PLoS One 2013;8:53801
   Web of Science ®Google Scholar
• Legro RS, Kunselman AR and Dodson WC. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 2009;84:165–9
   Google Scholar
• Glueck CJ, Goldenberg N and Pranikoff Jet al. Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome. Curr Med Res Opin 2013;29:55–62
   PubMed Web of Science ®Google Scholar
• Ryan EA. Hormones and insulin resistance during pregnancy. Lancet 2009;362:1777–8
   Google Scholar
• Nelson SM, Matthews P and Poston L. Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Hum Reprod 2010;16:255–75
   Web of Science ®Google Scholar
• Boomsma CM, Eijkemans MI and Hughes EGet al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod 2006;12:673–8
   Web of Science ®Google Scholar
• D’Anna R, Di Benedetto V and Rizzo Pet al. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecol Endocrinol 2012;28:440–2
   PubMed Web of Science ®Google Scholar
• Palomba S, Falbo A and Russo Tet al. The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome. Diabetes Care 2012;35:861–7
   PubMed Web of Science ®Google Scholar
• Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab 2006;20:281–92
   PubMed Web of Science ®Google Scholar
• Legro RS, Barnhart HX and Schlaff WDet al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551–66
   PubMed Web of Science ®Google Scholar
• Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab 2006;20:235–44
   PubMed Web of Science ®Google Scholar
• Boomsma CM, Fauser BC and Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008;1:72–84
   Google Scholar
• Palomba S, Falbo A and Russo Tet al. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril 2010;94:1805–11
   PubMed Web of Science ®Google Scholar
• Carmina E. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Gynecol 2004;56:1–6
   PubMedGoogle Scholar
• Vanky E, Stridsklev S and Heimstad Ret al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010;95:E448–55
   PubMed Web of Science ®Google Scholar